Brief Survey on MS: (more...)
In order to provide you with CME programs that meet your specific needs and competencies, we are conducting a brief multiple sclerosis survey to those who have expressed interest in our past educational initiatives. We would like to thank you in advance for your participation. Source: Projects In Knowledge

Story tips for journalists
EurekAlert! Tue, 18 Sep 2007 7:57 AM PDT
Here is a great thought…the arduous task of filling out boring questionnaires may soon be obsolete! Well, at least for people with multiple sclerosis (MS) whose activity levels must be monitored by doctors.

Out of the Gate: Millennium Pharma Rises
The Associated Press -
Its other drug candidates include MLN1202 for multiple sclerosis and MLN3897 for rheumatoid arthritis, both in mid-stage testing, and two cancer drugs in ...
See all stories on this topic

Bayer completes acquisition of US biologics manufacturing facility ...
Chemie.de (press release) - Germany
17 Sep 2007 - Bayer Schering Pharma AG, Germany, has completed the acquisition of a biologics manufacturing facility in Emeryville, California from Novartis ...
See all stories on this topic